H.R. 7180House117th Congress (2021-2023)Passed House

Brycen Gray and Ben Price COVID–19 Cognitive Research Act

Introduced March 21, 2022

AI-Generated Summary

Updated February 8, 2026 at 10:12 AM UTC

The Brycen Gray and Ben Price COVID‑19 Cognitive Research Act directs the National Science Foundation (NSF) to fund research on how COVID‑19 infection disrupts normal cognitive processes, especially in children and adolescents. It also requires the National Academies to study the issue and report findings. The law provides up to $10 million in funding through 2025 to support these efforts.

Key Provisions

  • NSF Director may award competitive, merit‑reviewed grants—using mechanisms like RAPID—to universities or nonprofit‑university consortia for interdisciplinary studies on COVID‑19‑related cognitive disruption.
  • Research topics may include basic studies of cognition, emotion, brain structure, predictive frameworks, tool development, and the role of psychological, social, and economic factors.
  • Within 45 days of enactment, NSF must contract with the National Academies to conduct a study reviewing literature, identifying gaps, assessing causal methods, and recommending coordination of research, especially for under‑represented groups and youth.
  • The National Academies must complete the study within 16 months and submit a report to NSF and Congress; NSF must then provide a summary of any implementation plans within three months of receiving the report.
  • Appropriations authorize up to $10 million for FY2023‑FY2025, including $1 million specifically for the National Academies study and related reporting.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

14 earlier actions
SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

July 27, 2022

View full timeline
HouseIntro Referral

Introduced in House

March 21, 2022

HouseIntro Referral

Referred to the House Committee on Science, Space, and Technology.

March 21, 2022

HouseCommittee

Committee Consideration and Mark-up Session Held.

May 17, 2022

HouseCommittee

Ordered to be Reported by Voice Vote.

May 17, 2022

HouseCommittee

Reported by the Committee on Science, Space, and Technology. H. Rept. 117-371.

June 15, 2022

HouseCalendars

Placed on the Union Calendar, Calendar No. 282.

June 15, 2022

HouseFloor

Mr. Beyer moved to suspend the rules and pass the bill.

July 26, 2022 • 3:28 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H7101-7103)

July 26, 2022 • 3:28 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 7180.

July 26, 2022 • 3:29 PM

HouseFloor

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

July 26, 2022 • 3:40 PM

HouseFloor

Considered as unfinished business. (consideration: CR H7144-7145)

July 26, 2022 • 8:24 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 350 - 69 (Roll no. 391).(text: CR H7101)

July 26, 2022 • 8:34 PM

HouseFloor

On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 350 - 69 (Roll no. 391). (text: CR H7101)

July 26, 2022 • 8:34 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

July 26, 2022 • 8:34 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

July 27, 2022

Floor Debate

12 members

What members said about H.R. 7180 on the floor

7 Republicans5 Democrats
Joe Neguse
Rep. Joe NeguseD-CO-2 · Jul 26, 2022

Mr. Speaker, by direction of the Committee on Rules, I call up House Resolution 1254 and ask for its immediate consideration. Mr. Speaker, for the purpose of debate only, I yield the customary 30…

Michael C. Burgess
Rep. Michael C. BurgessR-TX-26 · Jul 26, 2022

Mr. Speaker, I thank Mr. Neguse for yielding me the customary 30 minutes, and I yield myself such time as I may consume. Mr. Speaker, today's rule provides for consideration of three bills, three…

Anthony Gonzalez
Rep. Anthony GonzalezR-OH-16 · Jul 26, 2022

Madam Speaker, I rise in support of my bill, the Brycen Gray and Ben Price COVID-19 Cognitive Research Act. I was proud to introduce this legislation alongside my friends Ms. Wild, Mr. Kinzinger, Mr.…

John Katko
Rep. John KatkoR-NY-24 · Jul 26, 2022

Mr. Speaker, I rise today to oppose the previous question so we can immediately consider H. Res. 1255 led by my good friend and colleague Michael Guest, the vice ranking member of the Committee on…

Daniel T. Kildee
Rep. Daniel T. KildeeD-MI-5 · Jul 26, 2022

Mr. Speaker, I thank the gentleman from Colorado (Mr. Neguse), my friend, for yielding to me to speak in favor of this rule, which includes consideration of legislation that I and others drafted, the…

Show 7 more
Michael Guest
Rep. Michael GuestR-MS-3 · Jul 26, 2022

Mr. Speaker, I rise to oppose the previous question so that we may immediately consider H. Res. 1255. This resolution expresses support for the United States Border Patrol agents and condemns the…

August Pfluger
Rep. August PflugerR-TX-11 · Jul 26, 2022

Mr. Speaker, I thank the ranking member for yielding. I rise today to oppose the previous question so we can immediately consider H.R. 1255 and bring forward my good friend Mr. Guest's resolution…

Frank D. Lucas
Rep. Frank D. LucasR-OK-3 · Jul 26, 2022

Mr. Speaker, I yield myself such time as I may consume. I rise in support of H.R. 7180, and I thank my colleague, Mr. Gonzalez, for introducing and championing this important legislation. The Brycen…

Ed Perlmutter
Rep. Ed PerlmutterD-CO-7 · Jul 26, 2022

Mr. Speaker, I thank my friend from Colorado for extending me 3 minutes. Mr. Speaker, I rise today in support of the previous question and the rule, especially the section regarding the Wildfire…

Donald S. Beyer, Jr.
Rep. Donald S. Beyer, Jr.D-VA-8 · Jul 26, 2022

Madam Speaker, I move to suspend the rules and pass the bill (H.R. 7180) to authorize the Director of the National Science Foundation to award grants to support research on the disruption of regular…

Jamaal Bowman
Rep. Jamaal BowmanD-NY-16 · Jul 26, 2022

Madam Speaker, had I been present, I would have voted yea on rollcall No. 386. Members Recorded Pursuant to House Resolution 8, 117th Congress Amodei (Balderson) Babin (Sessions) Blumenauer (Beyer)…

Thomas P. Tiffany
Rep. Thomas P. TiffanyR-WI-7 · Jul 26, 2022

Madam Speaker, on that I demand the yeas and nays.

Bill Text

4 versions available

Reading Mode
Latest
Referred in SenateIssued July 27, 2022

IIB

117th CONGRESS

2d Session

H. R. 7180

IN THE SENATE OF THE UNITED STATES

July 27, 2022

Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions

AN ACT

To authorize the Director of the National Science Foundation to award grants to support research on the disruption of regular cognitive processes associated with COVID–19 infection, and for other purposes.


1.

Short title

This Act may be cited as the Brycen Gray and Ben Price COVID–19 Cognitive Research Act.

2.

Definitions

In this Act—

(1)

the term Director means the Director of the National Science Foundation;

(2)

the term National Academies means the National Academies of Science, Engineering, and Medicine; and

(3)

the term eligible entity means an institution of higher education (as such term is defined in section 102 of the Higher Education Act of 1965 (20 U.S.C. 1002)) or a consortium composed of non-profit organizations and institutions of higher education.

3.

Findings

Congress makes the following findings:

(1)

The COVID–19 pandemic has disrupted nearly every aspect of life across the globe. Furthermore, it has produced major disruptions of individual’s physical and mental health, including with respect of children and adolescents.

(2)

Historical epidemiological perspectives suggest an association between exposure to general respiratory viruses and subsequent disruption of regular cognitive processes.

(3)

Early research suggests that one in three individuals diagnosed with a COVID–19 infection experiences a disruption of regular cognitive processes within six months of such diagnosis.

(4)

Research is urgently needed to better understand why disruption in regular cognitive processes occur in patients as a consequence of a COVID–19 infection and how long such disruptions can continue after recovery.

(5)

The National Science Foundation has a deep history of supporting interdisciplinary, basic research that spans the social, behavioral, and fundamental biological sciences and paves the way for scientific advancements.

4.

National Science Foundation research

The Director shall award grants to eligible entities, including through the RAPID funding mechanism, on a competitive, merit-reviewed basis to support interdisciplinary research on the disruption of regular cognitive processes associated with both short-term and long-term COVID–19 infections, including with respect to children and adolescents. Such research may include the following:

(1)

Foundational studies on the effects of cognition, emotion, and neural structure and function relating to any disruption of regular cognitive processes associated with COVID–19 infection.

(2)

Analysis of findings on the disruption of regular cognitive processes associated with COVID–19 infection, including the development of predictive theoretical frameworks to guide future research.

(3)

Development of physical and conceptual tools needed to evaluate cognition, emotion, and neural structure and function of the brain as a consequence of a COVID–19 infection, and the potential relevance of such infection to the disruption of regular cognitive processes.

(4)

Studies on the relevance of psychological and psychosocial factors, including major disruptions of physical health, mental health, and economic stability associated with the COVID–19 pandemic, on the disruption of regular cognitive processes, including an identification and evaluation of such factors.

(5)

Any other activities the Director determines will support interdisciplinary research and collaboration on the disruption of regular cognitive processes associated with COVID–19 infection, including with respect to children and adolescents.

5.

National Academies study on the disruption of cognitive processes associated with COVID–19 infection

(a)

Study

(1)

In general

Not later than 45 days after the date of the enactment of this Act, the Director shall enter into an agreement with the National Academies to study and produce a report on the disruption of cognitive processes associated with COVID–19 infection. The study shall—

(A)

review the research literature and identify research gaps regarding Federal programs and activities with roles in addressing both short-term and long-term consequences associated with COVID–19 infection;

(B)

assess the necessity of establishing causal inference approaches into research on the impacts of COVID–19 infection on cognitive processes to determine reverse causation;

(C)

evaluate and make recommendations regarding the coordination of research and data collection, including with respect to children and adolescents, to identify the disruption of regular cognitive processes associated with COVID–19 infection, including long-term COVID–19;

(D)

evaluate impacts of COVID–19 infection on populations under-represented in cognitive literature, such as poor, rural, and minority populations; and

(E)

make recommendations regarding ways to coordinate engagement with researchers and stakeholders from universities, industry, public health organizations, State and local governments, elementary and secondary educational organizations, and non-profit organizations to ensure that research, information, and best practices relating to the disruption of regular cognitive processes associated with COVID–19 infection, including long-term COVID–19, are shared among such entities.

(2)

Completion

The study required under paragraph (1) shall be completed by not later than the date that is 16 months after the date of the enactment of this Act.

(b)

Reports

(1)

By the National Academies

Upon completion of the study under subsection (a), the National Academies shall transmit to the Director and Congress a report on such study.

(2)

By the Director

Not later than three months after receipt of the report under paragraph (1), the Director shall transmit to Congress a summary of the Director’s plans, if any, to implement the recommendations of the National Academies contained in such report.

6.

Authorization of appropriations

There is authorized to be appropriated to the Director to carry out this Act $10,000,000 for fiscal year 2023, to remain available through fiscal year 2025, of which $1,000,000 is authorized to carry out the study and produce the reports under section 5.

Passed the House of Representatives July 26, 2022.

Cheryl L. Johnson,

Clerk.